Osage Venture Partners
VC Fund
Bala Cynwyd, United States
Osage Venture Partners is a VC fund in Bala Cynwyd focused on Software and Enterprise Software. Osage Venture Partners (OVP) invests in early stage, business-to-business (B2B) software companies headquartered on the East Coast from its offices just outside of Philadelphia, PA. With over $175M under management, OVP seeks to invest in determined and creative entrepreneurs and provide them with the assistance required to build high growthbusinesses.
- Total investments:
- 138
- Last investment:
- Lead investor:
- 31%
- Fund size:
- $135M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Osage Venture Partners invests in
Stages Osage Venture Partners invests in
Countries Osage Venture Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 11 contacts → | |||
Round size
- Seed
- $2M–$8.5M
- Series A
- $2.3M–$14M
- Series B
- $3.4M–$21M
Investment Focus
Industry
- Software 37 (27%)
- Enterprise Software 19 (14%)
- Information Technology 16 (12%)
- Artificial Intelligence 16 (12%)
- SaaS 14 (10%)
Stage
- Series A 43 (31%)
- Seed 20 (14%)
- Series B 18 (13%)
- Funding Round 14 (10%)
- Series C 6 (4%)
Country
- United States 73 (53%)
- Israel 1 (1%)
- Ireland 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Claudia Dunnous
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
Emily Foote
Principal
|
Principal | Total investments: 1 | Find email | |
James Quigley
Entrepreneur In Residence
|
Entrepreneur In Residence | Total investments: 1 | Find email | |
Jon Gulardo
Associate
|
Associate | Total investments: 0 | Find email | |
Michael Phelan
Venture Partner
|
Venture Partner | Total investments: 2 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Rep AI
|
Rep is an AI concierge for e-commerce websites, enabling conversational shopping for e-commerce on websites.Rep uses two types of AI. One tracks customer behavior and steps in when they're losing interest, thereby increasing conversions. The generative AI powered by ChatGPT helps shoppers find products, make recommendations, and even helpswith post-purchase tracking. | $6.2M / Series A / May 28, 2026 | |
Iridius
|
Iridius is the compliance-by-design AI platform that enables regulated enterprises to design, build, and operate AI systems that are continuously compliant. In regulated industries, AI isn’t failing because of model capability — it’s failing because it can’t operate within real-world constraints: fragmented systems, complex workflows, and strictregulatory compliance requirements. Instead of treating compliance as a manual process that happens after systems are built, Iridius makes compliance part of how systems run. | $8.6M / Seed / Apr 23, 2026 | |
Lin Health
|
Online integrative pain management. | $11M / Series A / Dec 08, 2025 | |
Returnalyze
|
Returnalyze is an ecommerce analytics company focused on helping retailers understand their product returns data. Returnalyze is the return optimization platform that increases top-line and bottom-line while allowing for a better consumer experience | $6M / Series A / Sep 16, 2025 | |
Dig
|
GlossAI bridges the gap between the content created by organisations and how people consume it .Today's audiences do not have the attention span to listen to anything for an extended period of time. Even those attending events, podcasts, training sessions, and zoom calls can't keep up. At GlossAI we get smart AI video generator that canturn any single piece of content into many short videos, blog posts and more various channels and use cases. | $14M / Series A / Feb 23, 2025 | |
Overland AI
|
Overland AI is a manufacturer and developer of autonomous navigation for off-road autonomous vehicles. | $32M / Series A / Jan 13, 2025 | |
Normunity
|
Normunity is a biotechnology company creating a new class of precision immuno-oncology medicines, called immune normalizers, that target novel mechanisms that free the body’s normal immunity against cancer.Based on an ongoing, interactive academic-biotech alliance with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is targetingnewly-discovered mechanisms of immune disruption in cancer based on proprietary discovery platforms that elucidate the complex interactions between human cancer and the immune system. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer.Normunity is located in Boston, Massachusetts and West Haven, Connecticut. | $75M / Series B / Jan 13, 2025 | |
Dataships
|
Dataships is a data privacy software and services company, specializing in automating GDPR and CCPA compliance. The company, which is co-located in Dublin and San Francisco, was founded by Ryan McErlane and Michael Storan in 2019. | $7M / Series A / Jan 05, 2025 | |
Knit
|
Based in Austin, Texas, Knit is the platform helping brands make customer-centric decisions through agile video feedback. Powered by a one-of-a-kind network of over 60K collegiate Gen Z-ers who are motivated by social causes, Knit enables its customers to make better, customer-centric decisions through Voice of Consumer videos. | $9M / Series A / Sep 18, 2024 | |
Knit
|
Knit pairs forward-deployed researchers with autonomous research agents to deliver decision-ready insights faster and better than traditional agencies, unlocking entirely new ways for the world's most iconic enterprises to run research. | $9M / Series A / Sep 18, 2024 | |
| See all 138 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Osage Venture Partners invest in?
Osage Venture Partners invests primarily in Software, Enterprise Software and Information Technology startups, most often at Series A and Seed stage. Most of the 138 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Osage Venture Partners's check size?
Osage Venture Partners typically joins rounds of $2M–$8.5M at Seed, $2.3M–$14M at Series A and $3.4M–$21M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Osage Venture Partners participates in.
How do I contact Osage Venture Partners?
Public channels for Osage Venture Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Osage Venture Partners?
The team at Osage Venture Partners includes Claudia Dunnous (Chief Financial Officer), Emily Foote (Principal) and James Quigley (Entrepreneur In Residence), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
